Patient Readiness to Adhere to HAART

Abstract

Objectives: to determine 1) whether patients’ statements of readiness to take HAART predicted adherence and 2) whether previous experience with HAART enabled patients to better predict adherence. Method: Thirty-nine patients (24 naïve to HAART and 15 reinitiating HAART after a hiatus of >6 months) indicated readiness to take HAART on a Likert scale and a visual analog scale (VAS). Adherence was measured by prescription renewals. Results: Participants were 72% male; 62% African/American; 23% Anglo-White, and 13% Hispanic. Patients considered themselves quite ready to initiate therapy on both scales. Adherence for 5 months ranged from 24% to 100%; mean = 68%; median = 78%. Adherence was not associated with readiness as measured by the Likert scale (F = .15, p = .86) or the VAS (r = -.078, p = .64). VAS readiness scores did not correlate with adherence for naïve (r = -.16; p = .47) or experienced (r = .09; p = .76) patients. Conclusions: Patients’ statements of readiness to take HAART do not predict their adherence.

Keywords

readiness highly active antiretroviral therapy adherence AIDS HIV infection

References

Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services; November 3, 2008: 1-139. http://www.aidsinfo.nih.gov. Accessed August 8, 2009.

Clumeck N. , Pozniak A. , Raffi F. , and the European AIDS Clinical Society Executive Committee. Guidelines for the Clinical Management and Treatment of HIV Infected Adults in Europe; October 8, 2008. http://www.europeanaidsclinicalsociety.org/guidelines. Accessed August 8, 2009.

Paterson DL , Swindells S. , Mohr J. , et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21-30.

Bangsberg DR , Hecht FM , Clague H. , et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;26(5):435-442.

Fehr JS , Nicca D. , Sendi P. , et al, and the Swiss HIV Cohort Study. Starting or changing therapy-a prospective study exploring antiretroviral decision-making. Infection. 2005;33(4):249-256.

Researchers study use of the ‘MATI’ for improving AIDS drug adherence. Early data confirm tool’s usefulness. AIDS Alert. 2005;20(10):115-116.

Balfour L. , Kowal J. , Silverman A. , et al. A randomized controlled psycho-education intervention trial: improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART. AIDS Care . 2006;18(7): 830-838.

Balfour L. , Tasca GA , Kowal J. , et al. Development and validation of the HIV medication readiness scale . Assessment. 2007;14(4): 408-416.

Highstein GR , Willey C. , Mundy LM Development of Stage of Readiness and decisional balance instruments: tools to enhance clinical decision-making for adherence to antiretroviral therapy. AIDS Behav. 2006 ;10(5):563-573.

10.

DeVellis RF Scale Development : Theory and Applications. 2nd ed. Thousand Oaks, CA: SAGE Publications; 2003.

11.

Grossberg R. , Gross R. Use of pharmacy refill data as a measure of antiretroviral adherence. Curr HIV/AIDS Rep. 2007;4(4): 187-191.

12.

Kitahata MM , Reed SF , Dillingham PW , et al. Pharmacy based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDs and death. Int J STD AIDS. 2004;15(12):808-810.